Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
2
×
national top stories
abbvie
adverum biotechnologies
albert bourla
ally bridge group
alzheimer's disease
amgen
amicus therapeutics
arvinas
batten disease
bayer
big data analytics
biogen
blackrock
boston
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer diagnostics
cancer immunotherapy
casdin capital
casimir trials
celenex
christine mcsherry
chuck schumer
clinial trials
clinical trials
crispr therapeutics
cystic fibrosis
dan chevallard
darolutamide
deals
detroit blog main
detroit top stories
What
bio
2
×
company
2
×
drug
acquisitions
albert
analysis
biggest
biotech
bourla
bring
ceo
crispr
develop
diseases
employing
future
genetic
goldfinch
imports
ipo
kidney
later
lead
maker
maps
measured
medicines
million
new
patients
pfizer
pfizer’s
raised
raises
revenue
roundup
studies
today
world’s
Language
unknown
unset
Current search:
bio
×
company
×
" national blog main "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More